Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2026 Filed Jun 10, 2026 20:10 UTC |
SANTINI GINODirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 8,700 | $0.00 Strike: $16.49 | $0.00 |
DisclosureSEC source: 0001276038-26-000006 · form4-06102026_040601.xml · derivative · entry 2 SANTINI GINO · CIK 0001276038 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,700 shares Expires 2026-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:10 UTC |
SANTINI GINODirector
|
Exercise / conversionCommon Stock | 8,700 | $16.49 | $143,463.00 |
DisclosureSEC source: 0001276038-26-000006 · form4-06102026_040601.xml · nonDerivative · entry 1 SANTINI GINO · CIK 0001276038 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:05 UTC |
Freund John GordonDirector
|
SaleCommon Stock | 20 | $34.05 | $681.00 |
DisclosureSEC source: 0001296771-26-000004 · form4-05202026_040501.xml · nonDerivative · entry 1 Freund John Gordon · CIK 0001296771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,952 Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:15 UTC |
Freund John GordonDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 8,700 | $0.00 Strike: $16.49 | $0.00 |
DisclosureSEC source: 0001296771-26-000002 · form4-05182026_040512.xml · derivative · entry 6 Freund John Gordon · CIK 0001296771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,700 shares Expires 2026-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:15 UTC |
Freund John GordonDirector
|
SaleCommon Stock | 4,127 | $34.54 | $142,546.58 |
DisclosureSEC source: 0001296771-26-000002 · form4-05182026_040512.xml · nonDerivative · entry 3 Freund John Gordon · CIK 0001296771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,972 Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:15 UTC |
Freund John GordonDirector
|
Exercise / conversionCommon Stock | 8,700 | $16.49 | $143,463.00 |
DisclosureSEC source: 0001296771-26-000002 · form4-05182026_040512.xml · nonDerivative · entry 2 Freund John Gordon · CIK 0001296771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:15 UTC |
Lurker NancyDirector
|
GrantCommon Stock | 8,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001450485-26-000009 · form4-05182026_040516.xml · nonDerivative · entry 1 Lurker Nancy · CIK 0001450485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,758 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:15 UTC |
Freund John GordonDirector
|
GrantCommon Stock | 8,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001296771-26-000002 · form4-05182026_040512.xml · nonDerivative · entry 1 Freund John Gordon · CIK 0001296771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,399 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:15 UTC |
SANTINI GINODirector
|
GrantCommon Stock | 8,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001276038-26-000002 · form4-05182026_040507.xml · nonDerivative · entry 1 SANTINI GINO · CIK 0001276038 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,783 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:15 UTC |
Paya Carlos VDirector
|
GrantCommon Stock | 8,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001606244-26-000002 · form4-05182026_040514.xml · nonDerivative · entry 1 Paya Carlos V · CIK 0001606244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,323 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:15 UTC |
Glancy Donovan MichaelDirector
|
GrantCommon Stock | 17,482 | $0.00 | $0.00 |
DisclosureSEC source: 0002134015-26-000005 · form4-05182026_040517.xml · nonDerivative · entry 1 Glancy Donovan Michael · CIK 0002134015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,482 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. 8,741 of the RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders; 8,741 of the RSUs vest on May 14, 2027, in each case subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:15 UTC |
BOHLIN GAREN GDirector
|
GrantCommon Stock | 8,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001254705-26-000004 · form4-05182026_040510.xml · nonDerivative · entry 1 BOHLIN GAREN G · CIK 0001254705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,000 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:15 UTC |
Balice-Gordon Rita J.Director
|
GrantCommon Stock | 8,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001825625-26-000002 · form4-05182026_040509.xml · nonDerivative · entry 1 Balice-Gordon Rita J. · CIK 0001825625 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,370 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:05 UTC |
Lurker NancyDirector
|
SaleCommon Stock | 4,500 | $35.97 | $161,860.95 |
DisclosureSEC source: 0001450485-26-000007 · form4-05152026_040505.xml · nonDerivative · entry 1 Lurker Nancy · CIK 0001450485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,017 F1 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.55 to $36.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:05 UTC |
BOHLIN GAREN GDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 8,700 | $0.00 Strike: $16.49 | $0.00 |
DisclosureSEC source: 0001254705-26-000002 · form4-05132026_040501.xml · derivative · entry 3 BOHLIN GAREN G · CIK 0001254705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,700 shares Expires 2026-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:05 UTC |
BOHLIN GAREN GDirector
|
SaleCommon Stock | 8,700 | $37.18 | $323,491.23 |
DisclosureSEC source: 0001254705-26-000002 · form4-05132026_040501.xml · nonDerivative · entry 2 BOHLIN GAREN G · CIK 0001254705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,259 F1 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.18 to $37.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:05 UTC |
BOHLIN GAREN GDirector
|
Exercise / conversionCommon Stock | 8,700 | $16.49 | $143,463.00 |
DisclosureSEC source: 0001254705-26-000002 · form4-05132026_040501.xml · nonDerivative · entry 1 BOHLIN GAREN G · CIK 0001254705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2026 Filed Mar 20, 2026 21:14 UTC |
Dieter DavidEVP & General Counsel
|
SaleCommon Stock | 13,976 | $34.92 | $488,099.22 |
DisclosureSEC source: 0002061438-26-000006 · form4-03202026_090345.xml · nonDerivative · entry 1 Dieter David · CIK 0002061438 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,071 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.74 to $35.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 17, 2026 Filed Apr 3, 2026 20:46 UTC |
Dieter DavidEVP & General Counsel
|
Tax withholdingCommon Stock | 8,840 | $35.72 | $315,764.80 |
DisclosureSEC source: 0002061438-26-000009 · form4-04032026_080415.xml · nonDerivative · entry 1 Dieter David · CIK 0002061438 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,231 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:10 UTC |
Dieter DavidEVP & General Counsel
|
SaleCommon Stock | 6,224 | $36.65 | $228,109.60 |
DisclosureSEC source: 0002061438-26-000004 · form4-03112026_080318.xml · nonDerivative · entry 1 Dieter David · CIK 0002061438 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,047 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 21:29 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
SaleCommon Stock | 3,559 | $40.99 | $145,879.50 |
DisclosureSEC source: 0001746251-26-000004 · form4-03052026_090346.xml · nonDerivative · entry 2 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,770 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.84 to $41.35, inclusive. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 21:29 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
SaleCommon Stock | 46,417 | $40.36 | $1,873,557.22 |
DisclosureSEC source: 0001746251-26-000004 · form4-03052026_090346.xml · nonDerivative · entry 1 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,329 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.835 to $40.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:30 UTC |
Dieter DavidEVP & General Counsel
|
Tax withholdingCommon Stock | 2,781 | $46.75 | $130,011.75 |
DisclosureSEC source: 0002061438-26-000002 · form4-02122026_040219.xml · nonDerivative · entry 3 Dieter David · CIK 0002061438 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,271 F4 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:30 UTC |
Dieter DavidEVP & General Counsel
|
GrantCommon Stock | 9,005 | $0.00 | $0.00 |
DisclosureSEC source: 0002061438-26-000002 · form4-02122026_040219.xml · nonDerivative · entry 2 Dieter David · CIK 0002061438 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,052 F3 · shares: Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 9,005 performance share units ("PSUs") granted in the Issuer's 2025 fiscal year. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:30 UTC |
Dieter DavidEVP & General Counsel
|
GrantCommon Stock | 22,194 | $0.00 | $0.00 |
DisclosureSEC source: 0002061438-26-000002 · form4-02122026_040219.xml · nonDerivative · entry 1 Dieter David · CIK 0002061438 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,047 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. F2 · balance_after: Includes 404 shares acquired on January 16, 2026 under the Issuer's employee stock purchase plan. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:30 UTC |
Tupper ColleenEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 26,679 | $46.75 | $1,247,243.25 |
DisclosureSEC source: 0001862082-26-000002 · form4-02122026_040203.xml · nonDerivative · entry 4 Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,282 F4 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:30 UTC |
Tupper ColleenEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 11,861 | $46.75 | $554,501.75 |
DisclosureSEC source: 0001862082-26-000002 · form4-02122026_040203.xml · nonDerivative · entry 3 Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,961 F3 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:30 UTC |
Tupper ColleenEVP & Chief Financial Officer
|
GrantCommon Stock | 32,734 | $0.00 | $0.00 |
DisclosureSEC source: 0001862082-26-000002 · form4-02122026_040203.xml · nonDerivative · entry 2 Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,822 F2 · shares: Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 32,734 performance share units ("PSUs") granted in the Issuer's three prior fiscal years. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:30 UTC |
Tupper ColleenEVP & Chief Financial Officer
|
GrantCommon Stock | 26,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001862082-26-000002 · form4-02122026_040203.xml · nonDerivative · entry 1 Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,088 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:30 UTC |
Karnani VikramDirector · President and CEO
|
Tax withholdingCommon Stock | 11,296 | $46.75 | $528,088.00 |
DisclosureSEC source: 0001699488-26-000002 · form4-02122026_040217.xml · nonDerivative · entry 3 Karnani Vikram · CIK 0001699488 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,864 F4 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:30 UTC |
Karnani VikramDirector · President and CEO
|
GrantCommon Stock | 32,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001699488-26-000002 · form4-02122026_040217.xml · nonDerivative · entry 2 Karnani Vikram · CIK 0001699488 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,160 F3 · shares: Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 32,531 performance share units ("PSUs") granted in the Issuer's 2025 fiscal year. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:30 UTC |
Karnani VikramDirector · President and CEO
|
GrantCommon Stock | 79,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001699488-26-000002 · form4-02122026_040217.xml · nonDerivative · entry 1 Karnani Vikram · CIK 0001699488 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,629 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. F2 · balance_after: Includes 376 shares acquired on July 18, 2025 under the Issuer's employee stock purchase plan. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:30 UTC |
Smith Thomas BEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 11,538 | $46.75 | $539,401.50 |
DisclosureSEC source: 0001748462-26-000002 · form4-02122026_040205.xml · nonDerivative · entry 4 Smith Thomas B · CIK 0001748462 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,651 F5 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:30 UTC |
Smith Thomas BEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 5,897 | $46.75 | $275,684.75 |
DisclosureSEC source: 0001748462-26-000002 · form4-02122026_040205.xml · nonDerivative · entry 3 Smith Thomas B · CIK 0001748462 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,189 F4 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:30 UTC |
Smith Thomas BEVP and Chief Medical Officer
|
GrantCommon Stock | 22,774 | $0.00 | $0.00 |
DisclosureSEC source: 0001748462-26-000002 · form4-02122026_040205.xml · nonDerivative · entry 2 Smith Thomas B · CIK 0001748462 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,086 F3 · shares: Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 22,774 performance share units ("PSUs") granted in the Issuer's three prior fiscal years. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:30 UTC |
Smith Thomas BEVP and Chief Medical Officer
|
GrantCommon Stock | 14,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001748462-26-000002 · form4-02122026_040205.xml · nonDerivative · entry 1 Smith Thomas B · CIK 0001748462 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,312 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. F2 · balance_after: Includes 376 and 404 shares acquired on July 18, 2025 and January 16, 2026, respectively, under the Issuer's employee stock purchase plan. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:30 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
Tax withholdingCommon Stock | 21,615 | $46.75 | $1,010,501.25 |
DisclosureSEC source: 0001746251-26-000002 · form4-02122026_040201.xml · nonDerivative · entry 4 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,746 F4 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:30 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
Tax withholdingCommon Stock | 9,977 | $46.75 | $466,424.75 |
DisclosureSEC source: 0001746251-26-000002 · form4-02122026_040201.xml · nonDerivative · entry 3 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,361 F3 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:30 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
GrantCommon Stock | 30,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001746251-26-000002 · form4-02122026_040201.xml · nonDerivative · entry 2 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,338 F2 · shares: Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 30,702 performance share units ("PSUs") granted in the Issuer's three prior fiscal years. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:30 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
GrantCommon Stock | 19,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001746251-26-000002 · form4-02122026_040201.xml · nonDerivative · entry 1 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,636 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:32 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 17,600 | $0.00 Strike: $15.90 | $0.00 |
DisclosureSEC source: 0001746251-25-000004 · form4-12102025_091236.xml · derivative · entry 4 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,600 shares Expires 2029-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:32 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
SaleCommon Stock | 6,475 | $48.66 | $315,084.51 |
DisclosureSEC source: 0001746251-25-000004 · form4-12102025_091236.xml · nonDerivative · entry 3 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,613 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.215 to $49.08, inclusive. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:32 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
SaleCommon Stock | 11,125 | $47.89 | $532,770.69 |
DisclosureSEC source: 0001746251-25-000004 · form4-12102025_091236.xml · nonDerivative · entry 2 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,088 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.212 to $48.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:32 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
Exercise / conversionCommon Stock | 17,600 | $15.90 | $279,840.00 |
DisclosureSEC source: 0001746251-25-000004 · form4-12102025_091236.xml · nonDerivative · entry 1 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 21:22 UTC |
Balice-Gordon Rita J.Director
|
SaleCommon Stock | 3,650 | $47.03 | $171,673.37 |
DisclosureSEC source: 0001825625-25-000004 · form4-12092025_091255.xml · nonDerivative · entry 1 Balice-Gordon Rita J. · CIK 0001825625 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,629 F1 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.0301 to $47.0901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:10 UTC |
Fallon John A.Director
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 19,853 | $0.00 Strike: $9.33 | $0.00 |
DisclosureSEC source: 0001560152-25-000004 · form4-11142025_091156.xml · derivative · entry 5 Fallon John A. · CIK 0001560152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,853 shares Expires 2027-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:10 UTC |
Fallon John A.Director
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 15,000 | $0.00 Strike: $16.49 | $0.00 |
DisclosureSEC source: 0001560152-25-000004 · form4-11142025_091156.xml · derivative · entry 4 Fallon John A. · CIK 0001560152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2026-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:10 UTC |
Fallon John A.Director
|
SaleCommon Stock | 34,853 | $47.21 | $1,645,535.60 |
DisclosureSEC source: 0001560152-25-000004 · form4-11142025_091156.xml · nonDerivative · entry 3 Fallon John A. · CIK 0001560152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,634 F1 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.805 to $47.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:10 UTC |
Fallon John A.Director
|
Exercise / conversionCommon Stock | 19,853 | $9.33 | $185,228.49 |
DisclosureSEC source: 0001560152-25-000004 · form4-11142025_091156.xml · nonDerivative · entry 2 Fallon John A. · CIK 0001560152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:10 UTC |
Fallon John A.Director
|
Exercise / conversionCommon Stock | 15,000 | $16.49 | $247,350.00 |
DisclosureSEC source: 0001560152-25-000004 · form4-11142025_091156.xml · nonDerivative · entry 1 Fallon John A. · CIK 0001560152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,634 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.